nodes	percent_of_prediction	percent_of_DWPC	metapath
Mepivacaine—Lidocaine—EGFR—lung cancer	0.00446	0.395	CrCbGaD
Mepivacaine—Lidocaine—CYP2A6—lung cancer	0.00364	0.322	CrCbGaD
Mepivacaine—Body temperature increased—Teniposide—lung cancer	0.00221	0.00385	CcSEcCtD
Mepivacaine—Loss of consciousness—Erlotinib—lung cancer	0.00221	0.00384	CcSEcCtD
Mepivacaine—Sweating—Irinotecan—lung cancer	0.0022	0.00382	CcSEcCtD
Mepivacaine—Vomiting—Pemetrexed—lung cancer	0.00219	0.00382	CcSEcCtD
Mepivacaine—Vomiting—Gefitinib—lung cancer	0.00218	0.00379	CcSEcCtD
Mepivacaine—Erythema—Vinorelbine—lung cancer	0.00217	0.00378	CcSEcCtD
Mepivacaine—Sweating—Gemcitabine—lung cancer	0.00214	0.00372	CcSEcCtD
Mepivacaine—Anxiety—Erlotinib—lung cancer	0.00213	0.00371	CcSEcCtD
Mepivacaine—Back pain—Vinorelbine—lung cancer	0.0021	0.00366	CcSEcCtD
Mepivacaine—Bradycardia—Irinotecan—lung cancer	0.00209	0.00364	CcSEcCtD
Mepivacaine—Sweating increased—Etoposide—lung cancer	0.00208	0.00362	CcSEcCtD
Mepivacaine—Anaphylactic shock—Topotecan—lung cancer	0.00207	0.00361	CcSEcCtD
Mepivacaine—Hypersensitivity—Teniposide—lung cancer	0.00206	0.00358	CcSEcCtD
Mepivacaine—Oedema—Erlotinib—lung cancer	0.00205	0.00357	CcSEcCtD
Mepivacaine—Nausea—Pemetrexed—lung cancer	0.00205	0.00357	CcSEcCtD
Mepivacaine—Sweating increased—Paclitaxel—lung cancer	0.00204	0.00355	CcSEcCtD
Mepivacaine—Nausea—Gefitinib—lung cancer	0.00204	0.00354	CcSEcCtD
Mepivacaine—Shock—Erlotinib—lung cancer	0.00202	0.00351	CcSEcCtD
Mepivacaine—Asthenia—Teniposide—lung cancer	0.002	0.00349	CcSEcCtD
Mepivacaine—Hyperhidrosis—Topotecan—lung cancer	0.002	0.00349	CcSEcCtD
Mepivacaine—Angioedema—Vinorelbine—lung cancer	0.00198	0.00345	CcSEcCtD
Mepivacaine—Pruritus—Teniposide—lung cancer	0.00198	0.00344	CcSEcCtD
Mepivacaine—Paraesthesia—Vinblastine—lung cancer	0.00191	0.00333	CcSEcCtD
Mepivacaine—Bradycardia—Cisplatin—lung cancer	0.0019	0.00331	CcSEcCtD
Mepivacaine—Hypertension—Vinorelbine—lung cancer	0.00187	0.00326	CcSEcCtD
Mepivacaine—Paraesthesia—Topotecan—lung cancer	0.00186	0.00324	CcSEcCtD
Mepivacaine—Chills—Irinotecan—lung cancer	0.00184	0.00321	CcSEcCtD
Mepivacaine—Tocainide—ALB—lung cancer	0.00184	0.163	CrCbGaD
Mepivacaine—Atrioventricular block—Doxorubicin—lung cancer	0.00182	0.00317	CcSEcCtD
Mepivacaine—Chills—Gemcitabine—lung cancer	0.0018	0.00313	CcSEcCtD
Mepivacaine—Vomiting—Teniposide—lung cancer	0.00178	0.00309	CcSEcCtD
Mepivacaine—Anaphylactic shock—Vinorelbine—lung cancer	0.00177	0.00308	CcSEcCtD
Mepivacaine—Headache—Teniposide—lung cancer	0.00175	0.00305	CcSEcCtD
Mepivacaine—Erythema—Gemcitabine—lung cancer	0.00174	0.00304	CcSEcCtD
Mepivacaine—Tinnitus—Cisplatin—lung cancer	0.00174	0.00303	CcSEcCtD
Mepivacaine—Back pain—Irinotecan—lung cancer	0.00173	0.00301	CcSEcCtD
Mepivacaine—Tachycardia—Vinorelbine—lung cancer	0.00173	0.00301	CcSEcCtD
Mepivacaine—Bradycardia—Paclitaxel—lung cancer	0.00171	0.00297	CcSEcCtD
Mepivacaine—Back pain—Gemcitabine—lung cancer	0.00169	0.00294	CcSEcCtD
Mepivacaine—Nausea—Teniposide—lung cancer	0.00166	0.00289	CcSEcCtD
Mepivacaine—Hypotension—Vinorelbine—lung cancer	0.00165	0.00288	CcSEcCtD
Mepivacaine—Urticaria—Topotecan—lung cancer	0.00164	0.00286	CcSEcCtD
Mepivacaine—Body temperature increased—Topotecan—lung cancer	0.00164	0.00285	CcSEcCtD
Mepivacaine—Erythema—Cisplatin—lung cancer	0.00162	0.00283	CcSEcCtD
Mepivacaine—Body temperature increased—Erlotinib—lung cancer	0.00162	0.00282	CcSEcCtD
Mepivacaine—Syncope—Irinotecan—lung cancer	0.0016	0.00279	CcSEcCtD
Mepivacaine—Paraesthesia—Vinorelbine—lung cancer	0.00159	0.00277	CcSEcCtD
Mepivacaine—Loss of consciousness—Irinotecan—lung cancer	0.00157	0.00274	CcSEcCtD
Mepivacaine—Hypersensitivity—Vinblastine—lung cancer	0.00157	0.00273	CcSEcCtD
Mepivacaine—Tinnitus—Paclitaxel—lung cancer	0.00156	0.00272	CcSEcCtD
Mepivacaine—Hypertension—Irinotecan—lung cancer	0.00155	0.00269	CcSEcCtD
Mepivacaine—Chills—Etoposide—lung cancer	0.00153	0.00267	CcSEcCtD
Mepivacaine—Vision blurred—Cisplatin—lung cancer	0.00153	0.00267	CcSEcCtD
Mepivacaine—Anaphylactoid reaction—Methotrexate—lung cancer	0.00153	0.00266	CcSEcCtD
Mepivacaine—Asthenia—Vinblastine—lung cancer	0.00153	0.00266	CcSEcCtD
Mepivacaine—Hypersensitivity—Topotecan—lung cancer	0.00153	0.00266	CcSEcCtD
Mepivacaine—Tremor—Cisplatin—lung cancer	0.00152	0.00265	CcSEcCtD
Mepivacaine—Hypertension—Gemcitabine—lung cancer	0.00151	0.00262	CcSEcCtD
Mepivacaine—Chills—Paclitaxel—lung cancer	0.0015	0.00262	CcSEcCtD
Mepivacaine—Asthenia—Topotecan—lung cancer	0.00149	0.00259	CcSEcCtD
Mepivacaine—Asthenia—Erlotinib—lung cancer	0.00147	0.00256	CcSEcCtD
Mepivacaine—Pruritus—Topotecan—lung cancer	0.00146	0.00255	CcSEcCtD
Mepivacaine—Oedema—Irinotecan—lung cancer	0.00146	0.00254	CcSEcCtD
Mepivacaine—Anaphylactic shock—Irinotecan—lung cancer	0.00146	0.00254	CcSEcCtD
Mepivacaine—Erythema—Paclitaxel—lung cancer	0.00146	0.00254	CcSEcCtD
Mepivacaine—Pruritus—Erlotinib—lung cancer	0.00145	0.00252	CcSEcCtD
Mepivacaine—Back pain—Etoposide—lung cancer	0.00144	0.00251	CcSEcCtD
Mepivacaine—Shock—Irinotecan—lung cancer	0.00144	0.0025	CcSEcCtD
Mepivacaine—Tension—Paclitaxel—lung cancer	0.00143	0.00249	CcSEcCtD
Mepivacaine—Anaphylactic shock—Gemcitabine—lung cancer	0.00142	0.00248	CcSEcCtD
Mepivacaine—Oedema—Gemcitabine—lung cancer	0.00142	0.00248	CcSEcCtD
Mepivacaine—Nervousness—Paclitaxel—lung cancer	0.00142	0.00247	CcSEcCtD
Mepivacaine—Hyperhidrosis—Irinotecan—lung cancer	0.00141	0.00246	CcSEcCtD
Mepivacaine—Back pain—Paclitaxel—lung cancer	0.00141	0.00246	CcSEcCtD
Mepivacaine—Dizziness—Vinblastine—lung cancer	0.00141	0.00245	CcSEcCtD
Mepivacaine—Convulsion—Cisplatin—lung cancer	0.00141	0.00245	CcSEcCtD
Mepivacaine—Urticaria—Vinorelbine—lung cancer	0.00141	0.00245	CcSEcCtD
Mepivacaine—Body temperature increased—Vinorelbine—lung cancer	0.0014	0.00244	CcSEcCtD
Mepivacaine—Anxiety—Cisplatin—lung cancer	0.00138	0.0024	CcSEcCtD
Mepivacaine—Vision blurred—Paclitaxel—lung cancer	0.00138	0.0024	CcSEcCtD
Mepivacaine—Hyperhidrosis—Gemcitabine—lung cancer	0.00138	0.0024	CcSEcCtD
Mepivacaine—Dizziness—Topotecan—lung cancer	0.00137	0.00238	CcSEcCtD
Mepivacaine—Tremor—Paclitaxel—lung cancer	0.00137	0.00238	CcSEcCtD
Mepivacaine—Hypotension—Irinotecan—lung cancer	0.00136	0.00238	CcSEcCtD
Mepivacaine—Lidocaine—ABCB1—lung cancer	0.00136	0.12	CrCbGaD
Mepivacaine—Vomiting—Vinblastine—lung cancer	0.00135	0.00236	CcSEcCtD
Mepivacaine—Dizziness—Erlotinib—lung cancer	0.00135	0.00236	CcSEcCtD
Mepivacaine—Agitation—Paclitaxel—lung cancer	0.00134	0.00234	CcSEcCtD
Mepivacaine—Headache—Vinblastine—lung cancer	0.00134	0.00232	CcSEcCtD
Mepivacaine—Angioedema—Paclitaxel—lung cancer	0.00133	0.00232	CcSEcCtD
Mepivacaine—Hypotension—Gemcitabine—lung cancer	0.00133	0.00232	CcSEcCtD
Mepivacaine—Oedema—Cisplatin—lung cancer	0.00133	0.00231	CcSEcCtD
Mepivacaine—Anaphylactic shock—Cisplatin—lung cancer	0.00133	0.00231	CcSEcCtD
Mepivacaine—Anaphylactoid reaction—Doxorubicin—lung cancer	0.00132	0.00231	CcSEcCtD
Mepivacaine—Vomiting—Topotecan—lung cancer	0.00132	0.00229	CcSEcCtD
Mepivacaine—Paraesthesia—Irinotecan—lung cancer	0.00131	0.00228	CcSEcCtD
Mepivacaine—Syncope—Paclitaxel—lung cancer	0.00131	0.00228	CcSEcCtD
Mepivacaine—Loss of consciousness—Etoposide—lung cancer	0.00131	0.00228	CcSEcCtD
Mepivacaine—Hypersensitivity—Vinorelbine—lung cancer	0.0013	0.00227	CcSEcCtD
Mepivacaine—Vomiting—Erlotinib—lung cancer	0.0013	0.00227	CcSEcCtD
Mepivacaine—Somnolence—Irinotecan—lung cancer	0.0013	0.00226	CcSEcCtD
Mepivacaine—Headache—Topotecan—lung cancer	0.0013	0.00226	CcSEcCtD
Mepivacaine—Tachycardia—Cisplatin—lung cancer	0.00129	0.00225	CcSEcCtD
Mepivacaine—Convulsion—Etoposide—lung cancer	0.00129	0.00225	CcSEcCtD
Mepivacaine—Hypertension—Etoposide—lung cancer	0.00129	0.00224	CcSEcCtD
Mepivacaine—Headache—Erlotinib—lung cancer	0.00128	0.00223	CcSEcCtD
Mepivacaine—Loss of consciousness—Paclitaxel—lung cancer	0.00128	0.00223	CcSEcCtD
Mepivacaine—Hyperhidrosis—Cisplatin—lung cancer	0.00128	0.00223	CcSEcCtD
Mepivacaine—Paraesthesia—Gemcitabine—lung cancer	0.00128	0.00222	CcSEcCtD
Mepivacaine—Chills—Docetaxel—lung cancer	0.00128	0.00222	CcSEcCtD
Mepivacaine—Asthenia—Vinorelbine—lung cancer	0.00127	0.00221	CcSEcCtD
Mepivacaine—Nausea—Vinblastine—lung cancer	0.00127	0.0022	CcSEcCtD
Mepivacaine—Somnolence—Gemcitabine—lung cancer	0.00126	0.0022	CcSEcCtD
Mepivacaine—Convulsion—Paclitaxel—lung cancer	0.00126	0.0022	CcSEcCtD
Mepivacaine—Hypertension—Paclitaxel—lung cancer	0.00126	0.00219	CcSEcCtD
Mepivacaine—Pruritus—Vinorelbine—lung cancer	0.00125	0.00218	CcSEcCtD
Mepivacaine—Hypotension—Cisplatin—lung cancer	0.00124	0.00216	CcSEcCtD
Mepivacaine—Anxiety—Paclitaxel—lung cancer	0.00124	0.00216	CcSEcCtD
Mepivacaine—Erythema—Docetaxel—lung cancer	0.00124	0.00215	CcSEcCtD
Mepivacaine—Nausea—Topotecan—lung cancer	0.00123	0.00214	CcSEcCtD
Mepivacaine—Cardiac arrest—Doxorubicin—lung cancer	0.00122	0.00212	CcSEcCtD
Mepivacaine—Nausea—Erlotinib—lung cancer	0.00122	0.00212	CcSEcCtD
Mepivacaine—Anaphylactic shock—Etoposide—lung cancer	0.00121	0.00212	CcSEcCtD
Mepivacaine—Back pain—Docetaxel—lung cancer	0.0012	0.00208	CcSEcCtD
Mepivacaine—Oedema—Paclitaxel—lung cancer	0.00119	0.00207	CcSEcCtD
Mepivacaine—Anaphylactic shock—Paclitaxel—lung cancer	0.00119	0.00207	CcSEcCtD
Mepivacaine—Paraesthesia—Cisplatin—lung cancer	0.00119	0.00207	CcSEcCtD
Mepivacaine—Tachycardia—Etoposide—lung cancer	0.00119	0.00206	CcSEcCtD
Mepivacaine—Hyperhidrosis—Etoposide—lung cancer	0.00117	0.00205	CcSEcCtD
Mepivacaine—Shock—Paclitaxel—lung cancer	0.00117	0.00204	CcSEcCtD
Mepivacaine—Dizziness—Vinorelbine—lung cancer	0.00117	0.00204	CcSEcCtD
Mepivacaine—Tachycardia—Paclitaxel—lung cancer	0.00116	0.00202	CcSEcCtD
Mepivacaine—Body temperature increased—Irinotecan—lung cancer	0.00115	0.00201	CcSEcCtD
Mepivacaine—Hyperhidrosis—Paclitaxel—lung cancer	0.00115	0.00201	CcSEcCtD
Mepivacaine—Drowsiness—Methotrexate—lung cancer	0.00114	0.00199	CcSEcCtD
Mepivacaine—Hypotension—Etoposide—lung cancer	0.00114	0.00198	CcSEcCtD
Mepivacaine—Vomiting—Vinorelbine—lung cancer	0.00113	0.00196	CcSEcCtD
Mepivacaine—Body temperature increased—Gemcitabine—lung cancer	0.00112	0.00196	CcSEcCtD
Mepivacaine—Hypotension—Paclitaxel—lung cancer	0.00111	0.00194	CcSEcCtD
Mepivacaine—Headache—Vinorelbine—lung cancer	0.00111	0.00193	CcSEcCtD
Mepivacaine—Syncope—Docetaxel—lung cancer	0.00111	0.00193	CcSEcCtD
Mepivacaine—Sweating—Methotrexate—lung cancer	0.00109	0.0019	CcSEcCtD
Mepivacaine—Paraesthesia—Etoposide—lung cancer	0.00109	0.0019	CcSEcCtD
Mepivacaine—Loss of consciousness—Docetaxel—lung cancer	0.00109	0.00189	CcSEcCtD
Mepivacaine—Somnolence—Etoposide—lung cancer	0.00108	0.00188	CcSEcCtD
Mepivacaine—Hypersensitivity—Irinotecan—lung cancer	0.00108	0.00187	CcSEcCtD
Mepivacaine—Convulsion—Docetaxel—lung cancer	0.00107	0.00187	CcSEcCtD
Mepivacaine—Paraesthesia—Paclitaxel—lung cancer	0.00107	0.00186	CcSEcCtD
Mepivacaine—Hypertension—Docetaxel—lung cancer	0.00107	0.00186	CcSEcCtD
Mepivacaine—Somnolence—Paclitaxel—lung cancer	0.00106	0.00184	CcSEcCtD
Mepivacaine—Nausea—Vinorelbine—lung cancer	0.00105	0.00183	CcSEcCtD
Mepivacaine—Body temperature increased—Cisplatin—lung cancer	0.00105	0.00183	CcSEcCtD
Mepivacaine—Asthenia—Irinotecan—lung cancer	0.00105	0.00182	CcSEcCtD
Mepivacaine—Asthenia—Gemcitabine—lung cancer	0.00102	0.00178	CcSEcCtD
Mepivacaine—Anaphylactic shock—Docetaxel—lung cancer	0.00101	0.00176	CcSEcCtD
Mepivacaine—Oedema—Docetaxel—lung cancer	0.00101	0.00176	CcSEcCtD
Mepivacaine—Pruritus—Gemcitabine—lung cancer	0.00101	0.00175	CcSEcCtD
Mepivacaine—Shock—Docetaxel—lung cancer	0.000993	0.00173	CcSEcCtD
Mepivacaine—Drowsiness—Doxorubicin—lung cancer	0.000988	0.00172	CcSEcCtD
Mepivacaine—Tachycardia—Docetaxel—lung cancer	0.000985	0.00172	CcSEcCtD
Mepivacaine—Hypersensitivity—Cisplatin—lung cancer	0.000977	0.0017	CcSEcCtD
Mepivacaine—Dizziness—Irinotecan—lung cancer	0.000966	0.00168	CcSEcCtD
Mepivacaine—Urticaria—Etoposide—lung cancer	0.000965	0.00168	CcSEcCtD
Mepivacaine—Body temperature increased—Etoposide—lung cancer	0.00096	0.00167	CcSEcCtD
Mepivacaine—Tinnitus—Methotrexate—lung cancer	0.000955	0.00166	CcSEcCtD
Mepivacaine—Asthenia—Cisplatin—lung cancer	0.000951	0.00166	CcSEcCtD
Mepivacaine—Sweating—Doxorubicin—lung cancer	0.000947	0.00165	CcSEcCtD
Mepivacaine—Urticaria—Paclitaxel—lung cancer	0.000946	0.00165	CcSEcCtD
Mepivacaine—Hypotension—Docetaxel—lung cancer	0.000943	0.00164	CcSEcCtD
Mepivacaine—Body temperature increased—Paclitaxel—lung cancer	0.000942	0.00164	CcSEcCtD
Mepivacaine—Vomiting—Irinotecan—lung cancer	0.000929	0.00162	CcSEcCtD
Mepivacaine—Chills—Methotrexate—lung cancer	0.000919	0.0016	CcSEcCtD
Mepivacaine—Headache—Irinotecan—lung cancer	0.000915	0.00159	CcSEcCtD
Mepivacaine—Paraesthesia—Docetaxel—lung cancer	0.000907	0.00158	CcSEcCtD
Mepivacaine—Vomiting—Gemcitabine—lung cancer	0.000905	0.00158	CcSEcCtD
Mepivacaine—Bradycardia—Doxorubicin—lung cancer	0.000903	0.00157	CcSEcCtD
Mepivacaine—Somnolence—Docetaxel—lung cancer	0.000898	0.00156	CcSEcCtD
Mepivacaine—Hypersensitivity—Etoposide—lung cancer	0.000895	0.00156	CcSEcCtD
Mepivacaine—Erythema—Methotrexate—lung cancer	0.000892	0.00155	CcSEcCtD
Mepivacaine—Headache—Gemcitabine—lung cancer	0.000891	0.00155	CcSEcCtD
Mepivacaine—Hypersensitivity—Paclitaxel—lung cancer	0.000878	0.00153	CcSEcCtD
Mepivacaine—Asthenia—Etoposide—lung cancer	0.000872	0.00152	CcSEcCtD
Mepivacaine—Nausea—Irinotecan—lung cancer	0.000868	0.00151	CcSEcCtD
Mepivacaine—Back pain—Methotrexate—lung cancer	0.000862	0.0015	CcSEcCtD
Mepivacaine—Pruritus—Etoposide—lung cancer	0.00086	0.0015	CcSEcCtD
Mepivacaine—Asthenia—Paclitaxel—lung cancer	0.000855	0.00149	CcSEcCtD
Mepivacaine—Nausea—Gemcitabine—lung cancer	0.000845	0.00147	CcSEcCtD
Mepivacaine—Vomiting—Cisplatin—lung cancer	0.000843	0.00147	CcSEcCtD
Mepivacaine—Pruritus—Paclitaxel—lung cancer	0.000843	0.00147	CcSEcCtD
Mepivacaine—Vision blurred—Methotrexate—lung cancer	0.00084	0.00146	CcSEcCtD
Mepivacaine—Tinnitus—Doxorubicin—lung cancer	0.000827	0.00144	CcSEcCtD
Mepivacaine—Dizziness—Etoposide—lung cancer	0.000803	0.0014	CcSEcCtD
Mepivacaine—Body temperature increased—Docetaxel—lung cancer	0.000798	0.00139	CcSEcCtD
Mepivacaine—Chills—Doxorubicin—lung cancer	0.000796	0.00139	CcSEcCtD
Mepivacaine—Dizziness—Paclitaxel—lung cancer	0.000788	0.00137	CcSEcCtD
Mepivacaine—Nausea—Cisplatin—lung cancer	0.000788	0.00137	CcSEcCtD
Mepivacaine—Convulsion—Methotrexate—lung cancer	0.000773	0.00135	CcSEcCtD
Mepivacaine—Vomiting—Etoposide—lung cancer	0.000772	0.00135	CcSEcCtD
Mepivacaine—Erythema—Doxorubicin—lung cancer	0.000772	0.00134	CcSEcCtD
Mepivacaine—Headache—Etoposide—lung cancer	0.000761	0.00133	CcSEcCtD
Mepivacaine—Tension—Doxorubicin—lung cancer	0.000758	0.00132	CcSEcCtD
Mepivacaine—Vomiting—Paclitaxel—lung cancer	0.000757	0.00132	CcSEcCtD
Mepivacaine—Nervousness—Doxorubicin—lung cancer	0.00075	0.00131	CcSEcCtD
Mepivacaine—Back pain—Doxorubicin—lung cancer	0.000747	0.0013	CcSEcCtD
Mepivacaine—Headache—Paclitaxel—lung cancer	0.000746	0.0013	CcSEcCtD
Mepivacaine—Hypersensitivity—Docetaxel—lung cancer	0.000744	0.0013	CcSEcCtD
Mepivacaine—Anaphylactic shock—Methotrexate—lung cancer	0.000728	0.00127	CcSEcCtD
Mepivacaine—Vision blurred—Doxorubicin—lung cancer	0.000728	0.00127	CcSEcCtD
Mepivacaine—Asthenia—Docetaxel—lung cancer	0.000724	0.00126	CcSEcCtD
Mepivacaine—Nausea—Etoposide—lung cancer	0.000722	0.00126	CcSEcCtD
Mepivacaine—Pruritus—Docetaxel—lung cancer	0.000714	0.00124	CcSEcCtD
Mepivacaine—Agitation—Doxorubicin—lung cancer	0.00071	0.00124	CcSEcCtD
Mepivacaine—Nausea—Paclitaxel—lung cancer	0.000708	0.00123	CcSEcCtD
Mepivacaine—Hyperhidrosis—Methotrexate—lung cancer	0.000703	0.00123	CcSEcCtD
Mepivacaine—Syncope—Doxorubicin—lung cancer	0.000692	0.00121	CcSEcCtD
Mepivacaine—Hypotension—Methotrexate—lung cancer	0.00068	0.00118	CcSEcCtD
Mepivacaine—Loss of consciousness—Doxorubicin—lung cancer	0.000679	0.00118	CcSEcCtD
Mepivacaine—Convulsion—Doxorubicin—lung cancer	0.000669	0.00116	CcSEcCtD
Mepivacaine—Dizziness—Docetaxel—lung cancer	0.000668	0.00116	CcSEcCtD
Mepivacaine—Hypertension—Doxorubicin—lung cancer	0.000667	0.00116	CcSEcCtD
Mepivacaine—Anxiety—Doxorubicin—lung cancer	0.000655	0.00114	CcSEcCtD
Mepivacaine—Paraesthesia—Methotrexate—lung cancer	0.000653	0.00114	CcSEcCtD
Mepivacaine—Somnolence—Methotrexate—lung cancer	0.000647	0.00113	CcSEcCtD
Mepivacaine—Vomiting—Docetaxel—lung cancer	0.000642	0.00112	CcSEcCtD
Mepivacaine—Headache—Docetaxel—lung cancer	0.000633	0.0011	CcSEcCtD
Mepivacaine—Anaphylactic shock—Doxorubicin—lung cancer	0.00063	0.0011	CcSEcCtD
Mepivacaine—Oedema—Doxorubicin—lung cancer	0.00063	0.0011	CcSEcCtD
Mepivacaine—Shock—Doxorubicin—lung cancer	0.00062	0.00108	CcSEcCtD
Mepivacaine—Tachycardia—Doxorubicin—lung cancer	0.000615	0.00107	CcSEcCtD
Mepivacaine—Hyperhidrosis—Doxorubicin—lung cancer	0.000609	0.00106	CcSEcCtD
Mepivacaine—Nausea—Docetaxel—lung cancer	0.0006	0.00104	CcSEcCtD
Mepivacaine—Hypotension—Doxorubicin—lung cancer	0.000589	0.00103	CcSEcCtD
Mepivacaine—Urticaria—Methotrexate—lung cancer	0.000578	0.00101	CcSEcCtD
Mepivacaine—Body temperature increased—Methotrexate—lung cancer	0.000575	0.001	CcSEcCtD
Mepivacaine—Paraesthesia—Doxorubicin—lung cancer	0.000566	0.000985	CcSEcCtD
Mepivacaine—Somnolence—Doxorubicin—lung cancer	0.00056	0.000976	CcSEcCtD
Mepivacaine—Hypersensitivity—Methotrexate—lung cancer	0.000536	0.000934	CcSEcCtD
Mepivacaine—Asthenia—Methotrexate—lung cancer	0.000522	0.000909	CcSEcCtD
Mepivacaine—Pruritus—Methotrexate—lung cancer	0.000515	0.000897	CcSEcCtD
Mepivacaine—Urticaria—Doxorubicin—lung cancer	0.000501	0.000872	CcSEcCtD
Mepivacaine—Body temperature increased—Doxorubicin—lung cancer	0.000498	0.000867	CcSEcCtD
Mepivacaine—Dizziness—Methotrexate—lung cancer	0.000481	0.000838	CcSEcCtD
Mepivacaine—Hypersensitivity—Doxorubicin—lung cancer	0.000464	0.000808	CcSEcCtD
Mepivacaine—Vomiting—Methotrexate—lung cancer	0.000463	0.000806	CcSEcCtD
Mepivacaine—Headache—Methotrexate—lung cancer	0.000456	0.000794	CcSEcCtD
Mepivacaine—Asthenia—Doxorubicin—lung cancer	0.000452	0.000787	CcSEcCtD
Mepivacaine—Pruritus—Doxorubicin—lung cancer	0.000446	0.000776	CcSEcCtD
Mepivacaine—Nausea—Methotrexate—lung cancer	0.000432	0.000753	CcSEcCtD
Mepivacaine—Dizziness—Doxorubicin—lung cancer	0.000417	0.000726	CcSEcCtD
Mepivacaine—Vomiting—Doxorubicin—lung cancer	0.000401	0.000698	CcSEcCtD
Mepivacaine—Headache—Doxorubicin—lung cancer	0.000395	0.000687	CcSEcCtD
Mepivacaine—Nausea—Doxorubicin—lung cancer	0.000374	0.000652	CcSEcCtD
Mepivacaine—SCN4A—Developmental Biology—FGFR1—lung cancer	0.000372	0.000897	CbGpPWpGaD
Mepivacaine—SCN3A—Axon guidance—RAF1—lung cancer	0.000369	0.000891	CbGpPWpGaD
Mepivacaine—SCN3A—Axon guidance—ERBB2—lung cancer	0.000365	0.000881	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—KDR—lung cancer	0.000364	0.000879	CbGpPWpGaD
Mepivacaine—SCN8A—Axon guidance—VEGFA—lung cancer	0.000364	0.000877	CbGpPWpGaD
Mepivacaine—SCN8A—Axon guidance—NRAS—lung cancer	0.000359	0.000867	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—FGFR1—lung cancer	0.000358	0.000865	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—FGFR1—lung cancer	0.000358	0.000865	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—MET—lung cancer	0.000357	0.00086	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—RAF1—lung cancer	0.000355	0.000856	CbGpPWpGaD
Mepivacaine—SCN4A—Axon guidance—RAF1—lung cancer	0.000355	0.000856	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—FGFR1—lung cancer	0.000353	0.000852	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—ERBB2—lung cancer	0.000351	0.000847	CbGpPWpGaD
Mepivacaine—SCN4A—Axon guidance—ERBB2—lung cancer	0.000351	0.000847	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—KDR—lung cancer	0.00035	0.000845	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—KDR—lung cancer	0.00035	0.000845	CbGpPWpGaD
Mepivacaine—SCN5A—SIDS Susceptibility Pathways—EP300—lung cancer	0.000347	0.000838	CbGpPWpGaD
Mepivacaine—SCN8A—Axon guidance—MAPK3—lung cancer	0.000344	0.00083	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—MET—lung cancer	0.000343	0.000827	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—MET—lung cancer	0.000343	0.000827	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—RAF1—lung cancer	0.000342	0.000825	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—RAF1—lung cancer	0.000342	0.000825	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—RAF1—lung cancer	0.000341	0.000822	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—ERBB2—lung cancer	0.000338	0.000816	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—ERBB2—lung cancer	0.000338	0.000816	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—KDR—lung cancer	0.000338	0.000814	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—KDR—lung cancer	0.000338	0.000814	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—ERBB2—lung cancer	0.000337	0.000813	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—FOXO3—lung cancer	0.000334	0.000806	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—KDR—lung cancer	0.000333	0.000802	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—MET—lung cancer	0.00033	0.000797	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—MET—lung cancer	0.00033	0.000797	CbGpPWpGaD
Mepivacaine—SCN5A—SIDS Susceptibility Pathways—VEGFA—lung cancer	0.000329	0.000793	CbGpPWpGaD
Mepivacaine—SCN9A—Axon guidance—MMP9—lung cancer	0.000328	0.00079	CbGpPWpGaD
Mepivacaine—SCN8A—Axon guidance—EGFR—lung cancer	0.000327	0.00079	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—IL6R—lung cancer	0.000326	0.000786	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—MET—lung cancer	0.000325	0.000785	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—CREBBP—lung cancer	0.000325	0.000785	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—ITGB1—lung cancer	0.000322	0.000777	CbGpPWpGaD
Mepivacaine—SCN3A—Axon guidance—MMP9—lung cancer	0.000313	0.000756	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—IL6R—lung cancer	0.000312	0.000752	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—CREBBP—lung cancer	0.000311	0.000751	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—MMP2—lung cancer	0.000311	0.00075	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—MAP2K1—lung cancer	0.000311	0.000749	CbGpPWpGaD
Mepivacaine—SCN8A—Axon guidance—KRAS—lung cancer	0.000309	0.000746	CbGpPWpGaD
Mepivacaine—SCN9A—Axon guidance—SRC—lung cancer	0.000302	0.000729	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—MMP9—lung cancer	0.000301	0.000726	CbGpPWpGaD
Mepivacaine—SCN4A—Axon guidance—MMP9—lung cancer	0.000301	0.000726	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—IL6R—lung cancer	0.000299	0.000722	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—IL6R—lung cancer	0.000299	0.000722	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—CREBBP—lung cancer	0.000299	0.000721	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—CREBBP—lung cancer	0.000299	0.000721	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—MMP2—lung cancer	0.000297	0.000718	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—MAP2K1—lung cancer	0.000297	0.000717	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—HES1—lung cancer	0.000296	0.000714	CbGpPWpGaD
Mepivacaine—SCN9A—Axon guidance—VEGFA—lung cancer	0.000294	0.00071	CbGpPWpGaD
Mepivacaine—SCN9A—Axon guidance—NRAS—lung cancer	0.00029	0.000701	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—MMP9—lung cancer	0.00029	0.0007	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—MMP9—lung cancer	0.00029	0.0007	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—MMP9—lung cancer	0.000289	0.000697	CbGpPWpGaD
Mepivacaine—SCN3A—Axon guidance—SRC—lung cancer	0.000289	0.000697	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—IL6R—lung cancer	0.000289	0.000697	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—IL6R—lung cancer	0.000289	0.000697	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—CREBBP—lung cancer	0.000288	0.000696	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—CREBBP—lung cancer	0.000288	0.000696	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—MMP2—lung cancer	0.000286	0.000689	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—MMP2—lung cancer	0.000286	0.000689	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—MAP2K1—lung cancer	0.000285	0.000689	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—MAP2K1—lung cancer	0.000285	0.000689	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—IL6R—lung cancer	0.000284	0.000686	CbGpPWpGaD
Mepivacaine—SCN3A—Axon guidance—VEGFA—lung cancer	0.000281	0.000679	CbGpPWpGaD
Mepivacaine—SCN9A—Axon guidance—MAPK3—lung cancer	0.000278	0.000671	CbGpPWpGaD
Mepivacaine—SCN3A—Axon guidance—NRAS—lung cancer	0.000278	0.00067	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—SRC—lung cancer	0.000277	0.000669	CbGpPWpGaD
Mepivacaine—SCN4A—Axon guidance—SRC—lung cancer	0.000277	0.000669	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—MMP2—lung cancer	0.000276	0.000665	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—MMP2—lung cancer	0.000276	0.000665	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—RAF1—lung cancer	0.000275	0.000664	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—MAP2K1—lung cancer	0.000275	0.000664	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—MAP2K1—lung cancer	0.000275	0.000664	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—EP300—lung cancer	0.000274	0.000661	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—ERBB2—lung cancer	0.000272	0.000657	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—MMP2—lung cancer	0.000271	0.000655	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—MAP2K1—lung cancer	0.000271	0.000654	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—VEGFA—lung cancer	0.00027	0.000652	CbGpPWpGaD
Mepivacaine—SCN4A—Axon guidance—VEGFA—lung cancer	0.00027	0.000652	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—SRC—lung cancer	0.000268	0.000646	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—SRC—lung cancer	0.000268	0.000646	CbGpPWpGaD
Mepivacaine—SCN4A—Axon guidance—NRAS—lung cancer	0.000267	0.000644	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—NRAS—lung cancer	0.000267	0.000644	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—SRC—lung cancer	0.000266	0.000643	CbGpPWpGaD
Mepivacaine—SCN3A—Axon guidance—MAPK3—lung cancer	0.000266	0.000642	CbGpPWpGaD
Mepivacaine—SCN9A—Axon guidance—EGFR—lung cancer	0.000265	0.000639	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—RAF1—lung cancer	0.000263	0.000636	CbGpPWpGaD
Mepivacaine—SCN8A—Axon guidance—HRAS—lung cancer	0.000263	0.000634	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—ERBB2—lung cancer	0.000261	0.000629	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—VEGFA—lung cancer	0.000261	0.000629	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—VEGFA—lung cancer	0.000261	0.000629	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—VEGFA—lung cancer	0.000259	0.000626	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—NRAS—lung cancer	0.000257	0.000621	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—NRAS—lung cancer	0.000257	0.000621	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—STAT3—lung cancer	0.000257	0.00062	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—NRAS—lung cancer	0.000256	0.000618	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—MAPK3—lung cancer	0.000256	0.000617	CbGpPWpGaD
Mepivacaine—SCN4A—Axon guidance—MAPK3—lung cancer	0.000256	0.000617	CbGpPWpGaD
Mepivacaine—SCN3A—Axon guidance—EGFR—lung cancer	0.000253	0.000611	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—RAF1—lung cancer	0.000253	0.000611	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—RAF1—lung cancer	0.000253	0.000611	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—FGFR1—lung cancer	0.000252	0.000608	CbGpPWpGaD
Mepivacaine—SCN8A—Axon guidance—IL6—lung cancer	0.000252	0.000607	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—ERBB2—lung cancer	0.00025	0.000604	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—ERBB2—lung cancer	0.00025	0.000604	CbGpPWpGaD
Mepivacaine—SCN9A—Axon guidance—KRAS—lung cancer	0.00025	0.000603	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—MAPK3—lung cancer	0.000247	0.000595	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—MAPK3—lung cancer	0.000247	0.000595	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—MAPK3—lung cancer	0.000245	0.000592	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—RAF1—lung cancer	0.000244	0.000589	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—RAF1—lung cancer	0.000244	0.000589	CbGpPWpGaD
Mepivacaine—SCN4A—Axon guidance—EGFR—lung cancer	0.000243	0.000587	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—EGFR—lung cancer	0.000243	0.000587	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—ERBB2—lung cancer	0.000241	0.000583	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—ERBB2—lung cancer	0.000241	0.000583	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—RAF1—lung cancer	0.00024	0.00058	CbGpPWpGaD
Mepivacaine—SCN3A—Axon guidance—KRAS—lung cancer	0.000239	0.000577	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—ERBB2—lung cancer	0.000238	0.000574	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—KDR—lung cancer	0.000237	0.000573	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—EGFR—lung cancer	0.000235	0.000566	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—EGFR—lung cancer	0.000235	0.000566	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—MMP9—lung cancer	0.000234	0.000564	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—EGFR—lung cancer	0.000234	0.000563	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—MET—lung cancer	0.000232	0.00056	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—KRAS—lung cancer	0.00023	0.000554	CbGpPWpGaD
Mepivacaine—SCN4A—Axon guidance—KRAS—lung cancer	0.00023	0.000554	CbGpPWpGaD
Mepivacaine—SCN5A—SIDS Susceptibility Pathways—IL6—lung cancer	0.000227	0.000549	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—MMP9—lung cancer	0.000224	0.000539	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—EP300—lung cancer	0.000222	0.000535	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—KRAS—lung cancer	0.000222	0.000535	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—KRAS—lung cancer	0.000222	0.000535	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—KRAS—lung cancer	0.000221	0.000532	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—SRC—lung cancer	0.000215	0.00052	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—MMP9—lung cancer	0.000215	0.000518	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—MMP9—lung cancer	0.000215	0.000518	CbGpPWpGaD
Mepivacaine—SCN9A—Axon guidance—HRAS—lung cancer	0.000213	0.000513	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—EP300—lung cancer	0.000212	0.000511	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—VEGFA—lung cancer	0.00021	0.000506	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—STAT3—lung cancer	0.000208	0.000501	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—NRAS—lung cancer	0.000207	0.0005	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—MMP9—lung cancer	0.000207	0.0005	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—MMP9—lung cancer	0.000207	0.0005	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—SRC—lung cancer	0.000206	0.000497	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—MMP9—lung cancer	0.000204	0.000492	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—EP300—lung cancer	0.000204	0.000491	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—EP300—lung cancer	0.000204	0.000491	CbGpPWpGaD
Mepivacaine—SCN9A—Axon guidance—IL6—lung cancer	0.000203	0.000491	CbGpPWpGaD
Mepivacaine—SCN3A—Axon guidance—HRAS—lung cancer	0.000203	0.00049	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—IL6R—lung cancer	0.000203	0.00049	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—CREBBP—lung cancer	0.000203	0.000489	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—VEGFA—lung cancer	0.000201	0.000484	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—STAT3—lung cancer	0.000199	0.00048	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—MAPK3—lung cancer	0.000199	0.000479	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—NRAS—lung cancer	0.000198	0.000478	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—SRC—lung cancer	0.000198	0.000478	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—SRC—lung cancer	0.000198	0.000478	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—EP300—lung cancer	0.000196	0.000474	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—EP300—lung cancer	0.000196	0.000474	CbGpPWpGaD
Mepivacaine—SCN4A—Axon guidance—HRAS—lung cancer	0.000195	0.000471	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—HRAS—lung cancer	0.000195	0.000471	CbGpPWpGaD
Mepivacaine—SCN3A—Axon guidance—IL6—lung cancer	0.000195	0.000469	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—MMP2—lung cancer	0.000194	0.000467	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—MAP2K1—lung cancer	0.000193	0.000467	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—VEGFA—lung cancer	0.000193	0.000465	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—VEGFA—lung cancer	0.000193	0.000465	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—STAT3—lung cancer	0.000191	0.000461	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—STAT3—lung cancer	0.000191	0.000461	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—SRC—lung cancer	0.000191	0.000461	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—SRC—lung cancer	0.000191	0.000461	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—NRAS—lung cancer	0.00019	0.00046	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—NRAS—lung cancer	0.00019	0.00046	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—MAPK3—lung cancer	0.00019	0.000458	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—EGFR—lung cancer	0.000189	0.000456	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—HRAS—lung cancer	0.000188	0.000454	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—HRAS—lung cancer	0.000188	0.000454	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—SRC—lung cancer	0.000188	0.000454	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—HRAS—lung cancer	0.000188	0.000452	CbGpPWpGaD
Mepivacaine—SCN4A—Axon guidance—IL6—lung cancer	0.000187	0.000451	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—IL6—lung cancer	0.000187	0.000451	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—VEGFA—lung cancer	0.000186	0.000449	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—VEGFA—lung cancer	0.000186	0.000449	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—STAT3—lung cancer	0.000184	0.000444	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—STAT3—lung cancer	0.000184	0.000444	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—NRAS—lung cancer	0.000184	0.000443	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—NRAS—lung cancer	0.000184	0.000443	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—VEGFA—lung cancer	0.000183	0.000442	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—MAPK3—lung cancer	0.000182	0.00044	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—MAPK3—lung cancer	0.000182	0.00044	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—NRAS—lung cancer	0.000181	0.000437	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—EGFR—lung cancer	0.000181	0.000436	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—IL6—lung cancer	0.00018	0.000435	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—IL6—lung cancer	0.00018	0.000435	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—IL6—lung cancer	0.000179	0.000433	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—KRAS—lung cancer	0.000178	0.00043	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—MAPK3—lung cancer	0.000176	0.000424	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—MAPK3—lung cancer	0.000176	0.000424	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—EGFR—lung cancer	0.000174	0.000419	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—EGFR—lung cancer	0.000174	0.000419	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—MAPK3—lung cancer	0.000173	0.000418	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—RAF1—lung cancer	0.000172	0.000414	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—KRAS—lung cancer	0.000171	0.000412	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—ERBB2—lung cancer	0.00017	0.00041	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—EGFR—lung cancer	0.000167	0.000404	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—EGFR—lung cancer	0.000167	0.000404	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—AKT1—lung cancer	0.000166	0.000399	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—EGFR—lung cancer	0.000165	0.000398	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—KRAS—lung cancer	0.000164	0.000396	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—KRAS—lung cancer	0.000164	0.000396	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—KRAS—lung cancer	0.000158	0.000381	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—KRAS—lung cancer	0.000158	0.000381	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—KRAS—lung cancer	0.000156	0.000376	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—HRAS—lung cancer	0.000152	0.000366	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—MMP9—lung cancer	0.000146	0.000351	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—IL6—lung cancer	0.000145	0.00035	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—HRAS—lung cancer	0.000145	0.00035	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—HRAS—lung cancer	0.000139	0.000336	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—HRAS—lung cancer	0.000139	0.000336	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—IL6—lung cancer	0.000139	0.000335	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—EP300—lung cancer	0.000138	0.000333	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—HRAS—lung cancer	0.000134	0.000324	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—HRAS—lung cancer	0.000134	0.000324	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—SRC—lung cancer	0.000134	0.000324	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—AKT1—lung cancer	0.000134	0.000323	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—IL6—lung cancer	0.000133	0.000322	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—IL6—lung cancer	0.000133	0.000322	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—HRAS—lung cancer	0.000132	0.000319	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—VEGFA—lung cancer	0.000131	0.000315	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—STAT3—lung cancer	0.000129	0.000312	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—NRAS—lung cancer	0.000129	0.000312	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—IL6—lung cancer	0.000129	0.00031	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—IL6—lung cancer	0.000129	0.00031	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—AKT1—lung cancer	0.000128	0.000309	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—IL6—lung cancer	0.000127	0.000306	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—MAPK3—lung cancer	0.000124	0.000298	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—AKT1—lung cancer	0.000123	0.000297	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—AKT1—lung cancer	0.000123	0.000297	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—AKT1—lung cancer	0.000119	0.000286	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—AKT1—lung cancer	0.000119	0.000286	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—EGFR—lung cancer	0.000118	0.000284	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—KRAS—lung cancer	0.000111	0.000268	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—HRAS—lung cancer	9.45e-05	0.000228	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—IL6—lung cancer	9.04e-05	0.000218	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—AKT1—lung cancer	8.34e-05	0.000201	CbGpPWpGaD
